Literature DB >> 33162852

Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson's Disease, and Multiple Sclerosis: Diagnosis and Treatment.

Susan K Conroy1, Katherine B Brownlowe1, Thomas W McAllister1.   

Abstract

Depression is common among patients with neurologic disorders, and it has long been considered more difficult to treat than depression in the general population. In this review, the authors consider challenges in the diagnosis and treatment of depression among patients with stroke, traumatic brain injury, Parkinson's disease, and multiple sclerosis. For each disorder, the authors discuss the epidemiology and time course of depression as well as review the physiologic and psychological etiologies of depression. In addition, for each disorder, they review screening tools and diagnostic considerations, including differential diagnosis; discuss etiological factors, both neurobiological and psychological; and assess evidence for various depression treatments, including pharmacologic, psychosocial, and neuromodulatory therapies. The evidence suggests that depression is common among patients with neurologic disorders and that it is crucial for general psychiatrists to provide treatment for this population.
Copyright © by the American Psychiatric Association.

Entities:  

Keywords:  Depression; Neuropsychiatry/neurobiology; Parkinson’s disease; multiple sclerosis; stroke; traumatic brain injury

Year:  2020        PMID: 33162852      PMCID: PMC7587873          DOI: 10.1176/appi.focus.20200004

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  158 in total

1.  Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis.

Authors:  D C Mohr; D E Goodkin; J Islar; S L Hauser; C P Genain
Journal:  Arch Neurol       Date:  2001-07

2.  Cause of death in patients attending multiple sclerosis clinics.

Authors:  A D Sadovnick; K Eisen; G C Ebers; D W Paty
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

3.  Factors associated with post-stroke suicidal death.

Authors:  Jin Pyo Hong; Subin Park; Sung-Ho Ahn; Jong S Kim
Journal:  J Psychiatr Res       Date:  2017-10-07       Impact factor: 4.791

4.  Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial.

Authors:  Jesse R Fann; Charles H Bombardier; Nancy Temkin; Peter Esselman; Catherine Warms; Jason Barber; Sureyya Dikmen
Journal:  J Head Trauma Rehabil       Date:  2017 Sep/Oct       Impact factor: 2.710

5.  Interferon beta-1 a and depression in relapsing-remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial.

Authors:  S B Patten; L M Metz
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

6.  Depression and risk of stroke: a meta-analysis of prospective studies.

Authors:  Jia-Yi Dong; Yong-Hong Zhang; Jian Tong; Li-Qiang Qin
Journal:  Stroke       Date:  2011-10-20       Impact factor: 7.914

Review 7.  Pharmacologic treatment of depression in multiple sclerosis.

Authors:  Marcus W Koch; Arjon Glazenborg; Maarten Uyttenboogaart; Jop Mostert; Jacques De Keyser
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

8.  Depression in Parkinson's disease.

Authors:  S E Starkstein; T J Preziosi; P L Bolduc; R G Robinson
Journal:  J Nerv Ment Dis       Date:  1990-01       Impact factor: 2.254

9.  Prolonged Postconcussive Symptoms.

Authors:  Davin K Quinn; Andrew R Mayer; Christina L Master; Jesse R Fann
Journal:  Am J Psychiatry       Date:  2018-02-01       Impact factor: 18.112

10.  Restless leg syndrome: a risk factor of higher prevalence of anxiety and depression in Parkinson's disease patients.

Authors:  Abdul Qayyum Rana; Abdullah A Mosabbir; Abdul Rehman M Qureshi; Muhammad Abbas; Mohammad A Rana
Journal:  Neurol Res       Date:  2016-03-30       Impact factor: 2.448

View more
  3 in total

1.  NNDC Special Issue: Challenges of Mood Disorders Care.

Authors:  John F Greden; J Raymond DePaulo
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

2.  Effects of animal-assisted psychotherapy incorporating mindfulness and self-compassion in neurorehabilitation: a randomized controlled feasibility trial.

Authors:  Pascale Künzi; Michael Ackert; Martin Grosse Holtforth; Margret Hund-Georgiadis; Karin Hediger
Journal:  Sci Rep       Date:  2022-06-28       Impact factor: 4.996

3.  Measurement invariance of six language versions of the post-traumatic stress disorder checklist for DSM-5 in civilians after traumatic brain injury.

Authors:  Fabian Bockhop; Marina Zeldovich; Katrin Cunitz; Dominique Van Praag; Marjolein van der Vlegel; Tim Beissbarth; York Hagmayer; Nicole von Steinbuechel
Journal:  Sci Rep       Date:  2022-10-04       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.